PF4 and atherosclerosis: Interestingly, CCL5 and CXCL4 (platelet factor 4), one of the most abundant chemokines in platelets, can interact with each other to form heterodimers, which are particularly potent in the recruitment of monocytes [11] and were shown to modulate the severity of atherosclerosis, stroke, abdominal aneurysm, and myocardial infarction in mice [12,13,14,15,16].